The Epstein and Trump Story the Stupid Scandal Kept Us From Seeing

# The Epstein and Trump Story the Stupid Scandal Kept Us From Seeing

If a public cannot handle the truth, it should not be surprised when it is handed a lie. That is the first uncomfortable fact underneath the Trump–Epstein story, and it has nothing to do with who did what. It has to do with how a society metabolizes certain subjects — beauty, fertility, heredity, reproductive choice, human fitness, embryo selection, genomics, the engineering of longer lives. The instant any of them enters the room, the public grabs the bluntest word and the ugliest historical analogy within reach and swings. It does not draw distinctions. Pageantry gets fused with trafficking, IVF with eugenics, beauty with abuse, heredity with racism, a scientist's research with a criminal's fantasy — all of it mashed into one word and one reflex of disgust. And then the same public is baffled when politicians deny obvious associations, scientists retreat into euphemism, institutions bury their files, and powerful people start speaking in code. They are not always hiding crimes. Often they are hiding from the reflex — from a punishment structure that has made the honest sentence the single most dangerous thing a person can say out loud. This is what moral panic actually manufactures. Not truth — theater. It teaches everyone with something complicated to explain that the safest public statement is the least honest one, and then it mistakes the resulting silence for clarity. A society that cannot tell ordinary selection from coercive eugenics, lawful reproductive medicine from criminal exploitation, or adult social life from abuse has not earned an adult conversation, and it does not get one. It gets denial, misdirection, symbolic outrage, and a permanent children's version of history. This essay is not written inside that version. Start with a question that sounds like it has nothing to do with a scandal. What do a beauty pageant, a dating app, an IVF clinic, a genome-sequencing company, a life-extension startup, and a man who dreams of never dying all have in common? The answer is a single word, and it's one most people have been trained to flinch away from: **fitness.** Every one of those things is a way of appraising human beings — sizing them up, ranking them, and choosing among them by their traits. A pageant does it with a stage and a score. A fertility clinic does it with a genetic report. Transhumanism does it by trying to redesign the organism itself. Different tools, different centuries, the same ancient activity underneath: deciding which people, and which qualities, get chosen, rewarded, and carried into the future. This is not a fringe preoccupation, and it is not only the business of eccentric individuals. It runs through **laboratories, universities, biotech companies, and governments.** Harvard scientists build it; venture funds bankroll it; national health agencies write policy around it; state-funded biobanks supply the raw genetic data that make it work. Governments have always cared about the fitness of their populations — that appetite is what produced the horrors of twentieth-century eugenics, and it is also what produces twenty-first-century fertility policy, pronatalist politics, and public money for reproductive technology. The subject never disappeared. It changed its vocabulary and kept going. It is also the world where the two men whose names the scandal has fused together — Jeffrey Epstein and Donald Trump, who knew each other socially for years — both turn up, though at opposite ends of it and in ways the headlines never bother to describe. One end is dark, criminal, and secret. The other is public, lawful, and loud. Telling those two ends apart is the entire task, and it begins by refusing the one word the scandal trained everyone to shout instead of think. When a story becomes loud enough and ugly enough, it does the public's thinking for them. It gets everyone talking about one thing so hard that they stop noticing everything next to it. That is what the Epstein scandal has done. And the thing sitting right next to it — the thing almost nobody is looking at — is that human societies have never stopped sorting people by their traits, and that the sorting has lately moved into clinics, laboratories, and government policy in plain sight. ## The one word that ate everything Start by being honest about how the story actually gets told. It is not really told at all anymore; it is chanted. Pedophile, island, blackmail, cabal, secret list. The prosecutorial, tabloid, cable-news, podcast, and conspiracy economies have fed on this for years, and they have handed the public the same thing over and over: a lurid melodrama with a cast of monsters. Some of it is a half-digested internet mutation of QAnon and Pizzagate and the Satanic Panic, and underneath those you can still see the old antisemitic blood-libel — hidden elites secretly feeding on the innocent — wearing new digital clothes. That version is not just ugly. It makes people dumber at exactly the moment they need to be sharper. It flattens a complicated field — science, money, reproduction, ambition, institutions — into one moral scream. And the more the public repeats the word, the less it can see, because the word does something specific: it stops you from telling different things apart. A scientist who took the wrong man's money becomes a suspect. A genetics conversation becomes sinister. A stated ambition becomes indistinguishable from a sex crime. Proximity, patronage, shared ideas, actual crime, and coordinated plotting all get poured into the same bucket and stirred until they look like one thing. That is not analysis. It is a reflex dressed up as understanding. I have been calling this a **heat sink**, and I'll keep the word because it's the right one, but the plain version is plainer still: a story this hot pulls all the attention toward itself and away from everything around it. It doesn't have to be fake to do that. A real crime can still work as a distraction. And while the whole country stared at the island, something much bigger and much quieter kept moving. ## What their friendship actually was The public wants the Trump–Epstein story to be one thing, because one thing is easier to hate than a system is to understand. But the documented record points to something less satisfying than a villain team-up and more uncomfortable: a continuum. They were friends, and the cleanest evidence isn't an accusation — it's Trump's own voice, on the record, back when being close to Epstein was something to brag about rather than deny. In a 2002 profile of Epstein in *New York* magazine, Trump said he'd known the man for fifteen years, called him a "terrific guy" and great company, and — tellingly, for what this essay is about — framed the friendship in the language of beauty: a shared eye for beautiful women and the pleasures of an elite social life. Notice what that is. Trump's own public vocabulary for the affinity was the vocabulary of appraisal — beauty, desirability, status, sociability. That is the visible surface of the selection world this essay is tracing, and the two men turn up inside it together: a milieu of parties, fashion, and Palm Beach social theater, documented in 1992 footage from a Mar-a-Lago party and in photographs from a 1997 Victoria's Secret event. That is the layer everyone remembers, and it is real. But it is only the outer skin of something larger. Because the same 2002 profile did something almost nobody absorbed. In the space of a sentence, it slid from beautiful women to beautiful minds. It cast Epstein not merely as a man who liked attractive company, but as a collector of brilliant and powerful people — a financier who challenged Nobel laureates, cultivated scientists at Harvard and MIT, and told friends that his real trade was in people, the brilliant and the powerful, across politics and science alike. That pivot is the part the scandal buried. Two decades before the files and the memes, a single magazine profile had already sketched the pattern: for Epstein, the attractive and the brilliant were not two separate appetites. They were one appetite — a fascination with human quality, with sorting and collecting people by their traits — aimed at two different crowds. That is the through-line the public keeps missing. Pageants, modeling, elite access, reproductive fantasy, IVF, genomics, embryo selection, transhumanism — these are not scattered subjects from unrelated scandals. They are surfaces of a single question: which human traits get valued, chosen, rewarded, reproduced, and carried into the future. Once you can see the question, the two men stop looking like a matched pair of monsters and start looking like two figures standing at very different points along it. None of that means they ran a shared program. The record does not show Trump and Epstein collaborating on anything genetic, and this essay will not pretend it does — by 2019 Trump was describing the friendship as a distant memory and saying flatly that he "wasn't a fan." The point is more disciplined, and more interesting, than a conspiracy. Their friendship lived at the oldest and most social layer of selection: beauty, status, access, appraisal. From there the two men's paths forked. Epstein pushed the same sorting instinct down into biology — genetics, science patronage, cryonics, the fantasy of seeding the race with his own DNA. Trump pushed it out into spectacle and, eventually, statecraft — the pageants, the television, the modeling world, and, decades later, a federal campaign on IVF. One man theatricalized selection. The other tried to biologize it. The scandal frame mashes both into a single ugly word. The story underneath is the one worth telling: the slow migration of human selection out of the ballroom and into the laboratory. ## Selection didn't disappear. It just got embarrassed. Here is the thing people have trouble saying out loud. The word **eugenics** is so soaked in horror — forced sterilization, racial ranking, the camps — that we lost the ability to talk about **selection** at all, as if the crimes of the twentieth century had somehow repealed one of the basic facts of life. They didn't. Every living thing that reproduces sexually is caught up in selection, and so is every human society. Every dating market, every marriage, every beauty standard, every dowry, every debutante ball, every prestige school, every swipe on a dating app is a way of deciding which traits get noticed, rewarded, and passed on. Some of it is conscious, some of it isn't. None of it is neutral. The real moral question was never whether humans select — they always have and always will. The question is *how*: whether the sorting is forced or chosen, violent or consensual, hidden or honest, whether it locks people into castes or leaves them free. The crime of the old eugenics wasn't that anyone noticed heredity. It was that a government turned that noticing into sterilization laws and racial planning. We lost that distinction, and because we lost it, we now can't talk about fertility clinics, embryo testing, or genetic compatibility without either panicking or pretending none of it is happening — which is the worst possible reaction to something this consequential. And to be exact about what this is and is not: none of it is racial eugenics, supremacist doctrine, or coercive state breeding, and nothing here defends the twentieth century's crimes. The frame is broader and older than that. Human societies continuously generate selection systems, and most of them are ordinary, informal, and lawful — courtship, marriage markets, schools, professions, military fitness standards, immigration rules — right up until technology makes them explicit, at which point the old discomfort comes roaring back. The task is not to pretend the discomfort away. It is to keep the categories straight: ordinary selection is not coercion, lawful reproductive technology is not exploitation, and naming any of it is not endorsing its worst historical form. ## Pageants are the easiest example Long before anyone could read a genome, people built loud, public rituals for sizing each other up. Biologists have noticed for a long time that showing off is rarely random — the "handicap principle" says a costly display can be an honest signal precisely because it's hard to fake — and that's the deep background for why every society ends up staging some version of conspicuous comparison and treating it as meaningful. Beauty pageants are just one of those rituals, and they belong in this story only at that level: **adult women, on a stage, being ranked in public.** A pageant takes symmetry, poise, discipline, and charm and turns them into a score. Miss Universe is, plainly, an international beauty contest that for decades ran swimsuit and evening-gown rounds and has spent years fighting in public over which women even qualify to be up there. As a matter of business record, **Donald Trump owned the Miss Universe Organization from 1996, when he bought it from ITT Corporation, until September 2015, when — after NBC dropped him over his campaign comments about Mexican immigrants — he bought out NBC's stake and days later sold the whole thing to the talent agency WME/IMG.** That's a legal, public, on-the-record business fact, and it puts him inside the world of adult trait-ranking that pageants represent. It is not offered as evidence of anything else, and it doesn't need to be. And he didn't just own the ranking system — he ran it by hand. At the Miss USA 2009 pre-show, in audio leaked to TMZ that November, Trump can be heard walking the lineup of contestants (all adults) and explaining a practice he'd invented after buying the pageants: the judges' early picks, he complained, kept leaving out the women he found most beautiful, so the organization reserved the right to override them and guarantee a bloc of contestants automatic advancement — a rule he named, on the recording, "the Trump Rule." He had the women point out who *they* thought was most beautiful, sorted the chosen into a separate line that moved on, and left the rest behind; TMZ reported the rule waved through almost half the field. Carrie Prejean, Miss California that year and the eventual runner-up, described the same ritual in her 2009 memoir: Trump inspecting the lineup "closer than any general ever inspected a platoon," taking notes, dividing the room into the women he found attractive and the ones he didn't, with contestants left crying backstage. Whatever else it was, it is the cleanest possible illustration of this essay's point. The man didn't inherit a selection machine and leave it alone; he tuned it, named the override after himself, and made the standard, literally, his own eye. Pageants are useful because they say out loud what most of society does quietly: they rank people, attach prestige to a standard, and then argue about the standard as the culture shifts. When Miss America dropped its swimsuit competition in 2018, board chair Gretchen Carlson said the organization would stop judging women on outward appearance — and it was praised as a break from beauty-based ranking. But it didn't stop ranking anyone. It just changed what it was allowed to reward out loud. Miss Universe made the same move from the other side: in 2023 it let married women and mothers compete for the first time, and in 2024 it scrapped the upper age limit entirely. None of that ended the contest. The rules changed; the ranking didn't stop. And that's the whole point I need a reader to see: **a pageant is one grown-up, stylized way of doing in public what human beings have always done — decide which traits count.** You can watch that same reflex run through a single modern career. Before Erika Kirk led Turning Point USA, and before Donald Trump appointed her to the U.S. Air Force Academy's Board of Visitors in March 2026, she was Erika Lane Frantzve — **Miss Arizona USA 2012**, crowned on her twenty-third birthday, who went on to represent Arizona at **Miss USA 2012** in Las Vegas, the national pageant Trump's Miss Universe Organization owned at the time. She didn't place; Olivia Culpo won. The point isn't insinuation — nothing in the record suggests any personal tie between Trump and Frantzve back in 2012, and I'm not implying one. The point is the shape of the path. A pageant turns presentation and poise into public visibility; public visibility becomes a platform; a platform can become a seat at an institution. Frantzve won a state title, built a conservative media and nonprofit profile, and — after her husband, Charlie Kirk, was assassinated in September 2025 and she succeeded him as head of TPUSA — was named by the president to a federal military-academy board. Beauty and poise get judged on the pageant stage; message and loyalty get rewarded in the movement; official standing gets conferred by the appointment. The standard changes at every step. The sorting never stops. Her family background is only lightly on the record: her mother's years at General Electric and later in network security are documented, while a claim that her father was a Raytheon executive remains unverified — a research lead, not evidence. Once you see that, embryo testing and fertility genomics stop looking like something alien that fell out of the sky. They look like a newer way of doing a very old thing. ## The old thing, in new hands So while the public rehearsed the island story, the actual question — who has children, with whom, and by what standard — was quietly moving out of the ballroom and the church and the pageant stage and into the clinic, the lab, the app, and the insurance rule. That's the real story, and it's not hidden. It's published. Take **George Church**, the Harvard geneticist. He apologized in 2019 for taking about **$500,000 from Epstein between 2005 and 2007**, and admitted he kept in touch even after Epstein's 2008 conviction and sex-offender registration; he was among the scientists at a 2007 gathering on Epstein's island, as the *Boston Globe* and *Daily Beast* reported. Months later, on *60 Minutes* in December 2019, Church mentioned a genetics-based dating app his lab was building, incorporated that September with a cofounder. The idea, as *MIT Technology Review* laid out, was to run quietly in the background of ordinary dating services and keep two people who carry the same rare disease mutation from ever matching in the first place. Church called it voluntary disease prevention, not coercion; told *60 Minutes* you'd only learn who you *were* compatible with, not who you weren't; pointed to the decades-old Orthodox Jewish screening group Dor Yeshorim as his model; and, in a hastily posted FAQ, insisted the project was opposed to eugenics, noting that sequencing a genome then ran about $750 and could be folded into a dating subscription. Critics saw eugenics anyway, because the machinery still filters people by their genes no matter what the intent is. That fight isn't a sideshow. It's the exact question of our moment: **can voluntary genetic risk-reduction really be told apart from the coercive kind?** Church's own FAQ answered yes, and drew the line hard — it disavowed "governmental or community judgment, bullying, and coercion" and pointed to Dor Yeshorim, the Orthodox Jewish carrier-screening program that has driven diseases like Tay-Sachs toward disappearance in its communities entirely through voluntary matching. But the answer didn't matter. The December 2019 reaction fused Digid8 with Nazi eugenics on contact, the Epstein money supplied the accelerant, and the project stalled at the starting line — a placeholder website, effectively one employee, no launch — and then quietly vanished. That is the heat sink doing its work in miniature: the transparent, voluntary, disease-focused version of genetic matching was killed by panic, while the harder-edged commercial version — embryo scoring for a fee, traits included — kept right on growing. One limit belongs here, stated plainly, because the surrounding lore tends to inflate it. Church has long championed large-scale "genome writing" — the **GP-write** effort even explored synthesizing a whole human genome from scratch, including a minimal "blank slate" template into which variants could later be introduced — and that work is real, published, and at times unsettling. But it is **synthesis from reference sequences, not a composite "master fitness genome" assembled from the best traits of many real donors.** No paper, grant, or company describes the latter; Digid8 was a disease-screening filter and nothing more. Comb the scientific literature, the patent filings, and the company disclosures and you find no "golden genome," no "apex sequence," no project splicing the best alleles of every population into one optimized human. Those terms do exist in genomics — but they mean humdrum reference assemblies stitched from a few anonymous donors, coordinate systems for mapping DNA, not engineered supermen. And the reason isn't only that such a thing is illegal or unbuilt; it's that biology doesn't cooperate with the fantasy. There is no perfect genome to copy, not even in nature's most successful specimens: when Nir Barzilai's team sequenced hundreds of Ashkenazi centenarians, the people who sail past a hundred turned out to carry the usual five or six serious disease variants apiece, Alzheimer's markers included — they thrive not on clean code but on a handful of *resilience* genes that buffer the damage. Two deeper facts finish the idea off. **Epistasis** means a gene's effect depends on the genes around it, so an allele that helps in one genetic background can be inert or harmful in another — which is exactly why "harvest the best traits from every group and combine them" isn't a plan but a category error. **Pleiotropy** means single genes pull several levers at once, so selecting hard for the variants tied to intelligence tends to drag along raised risk for conditions like bipolar disorder. Add that the traits people dream of optimizing are spread across thousands of tiny-effect variants, and building a "superhuman" would demand flawless simultaneous edits at tens of thousands of sites, orders of magnitude beyond any current tool without catastrophic error. The component technologies are real and advancing in their separate silos — multiplex trait-splicing already works in animals, where Church's own de-extinction company, Colossal, edits dozens of genes at once to build cold-adapted elephants and dire-wolf proxies, and genome *recoding* can rewrite a cell to resist viruses — but the assembled human apex-genome remains a myth, and the honest version of this story says so out loud rather than letting the reader picture one humming away in a basement. Embryo testing makes that question sharper, and it already has a first case with a name. Screening embryos for single-gene disorders has been routine for years; what's new is scoring embryos for the statistical odds of complex conditions — and, more controversially, for traits. In September 2021, Bloomberg reported the birth of a girl named **Aurea**, screened by a New Jersey company called **Genomic Prediction**; a 2022 Columbia University bioethics journal walked through the uproar and described her parents choosing among **33 candidate embryos in 2020**, picking the one with the best odds against things like heart disease, diabetes, and breast cancer. The company's own people said they were by then testing for roughly **200 IVF clinics across six continents**, and that something like **60 percent of U.S. IVF embryos already get some kind of genetic testing** — which by itself should end the fantasy that selection quietly left modern life when the word became taboo. Other firms followed — MyOme, Orchid, Herasight — and the frontier kept pushing past disease into traits. Orchid and Herasight now run CLIA-certified labs offering polygenic embryo scoring, and *MIT Technology Review* named embryo scoring one of its ten breakthrough technologies for 2026. Herasight's panel reaches openly into cognitive ability: its CogPGT predictor, released in October 2025, claims to capture roughly sixteen percent of the variance in fluid intelligence and to hold up *within families* — the only comparison that matters when choosing between siblings — at a correlation near 0.45, which the company translates into an expected difference of about 8.5 IQ points between just three embryos, or roughly fifteen across ten. A February 2026 upgrade extended the method to families of non-European ancestry. In 2024 a *Guardian* investigation, working with the group Hope Not Hate, recorded staff at a U.S. startup called **Heliospect Genomics** offering to rank embryos by predicted IQ and other traits — drawing on the publicly funded UK Biobank — for couples paying up to roughly $50,000; selecting embryos for high IQ is banned in Britain but legal in the United States, and one figure tied to the company mused that lab-grown eggs might one day let couples build embryos "on an industrial scale" and hand-pick an elite few. The loudest of them, **Nucleus Genomics** — founded in New York in 2021 by a 21-year-old Penn dropout and Thiel fellow, Kian Sadeghi, and backed by Peter Thiel's Founders Fund — plastered the New York subway in November 2025 with the slogan **"Have your best baby"** and the web address *pickyourbaby.com*. Its own marketing pitches screening across **2,000-plus inherited conditions**, analysis of **up to 20 embryos**, "genetic optimization" over dozens of diseases and traits from eye color to height to IQ to Alzheimer's risk, a starting price around **$9,999 a month for four months** — roughly **$40,000** before the clinic's own costs — and use by **165-plus clinics**. It's worth saying flatly what the science says against the sales pitch: careful studies find the real gains small — a few IQ points, maybe an inch or two of height — the predictions shaky, and the long-term disease claims unknowable for decades. And yet surveys show most Americans, somewhere around **72 to 78 percent**, approve of the disease-screening uses — even as the fertility specialists who would actually perform them remain markedly more skeptical, and the American Society for Reproductive Medicine and others urge caution. That gap between an approving public and a wary profession is its own small model of the problem this essay is about: the people who best understand the limits are the least enthusiastic, and the advertising simply talks past them. The lesson isn't that selection is here for the first time. The lesson is that **the real dangers are fraud, false certainty, and inequality**, and a grown-up society governs those instead of pretending the whole thing is unprecedented. The next frontier stretches the same logic further. In **in vitro gametogenesis**, researchers try to make eggs and sperm from ordinary body cells. In Katsuhiko Hayashi's lab at Osaka University, mouse skin cells were turned into working eggs that produced healthy pups as early as 2016; by 2021 the full cycle had been rebuilt; and at a 2023 gene-editing summit in London, Hayashi reported making eggs from male cells and producing mice with two biological fathers. Human use is still far off and technically brutal. But the direction is obvious, and so is the consequence: once you can make many embryos instead of a few, the room to choose among them grows too. That's a reasonable inference, not a proven fact, and I'll flag it as such — but it's a strong one. When embryos stop being scarce, selection stops being limited. The money already believes it: Conception Biosciences, a Silicon Valley company backed by OpenAI's Sam Altman, is working to manufacture human eggs from ordinary blood cells, and researchers in the field have publicly floated human viability within roughly seven years. Whether that estimate holds or slips, the trajectory runs one way — toward more embryos, and therefore more choosing. Sitting alongside all this is the longevity-and-genomics world, which runs on the same fuel. Craig Venter — who died in April 2026, and who had helped sequence the first human genome — started **Human Longevity Inc.** in March 2014 with $70 million, bought twenty of Illumina's thousand-dollar-genome machines, and aimed to sequence something like **40,000 genomes a year**, pairing deep sequencing with scans to predict illness before symptoms. Venter, for what it's worth, was no genetic determinist — on finishing the genome he argued that humans simply don't carry enough genes for biology to be destiny, and that environment does most of the shaping, which is its own quiet rebuke to the fantasy that a person can be read straight off a chromosome. And here I want to be careful, because this is exactly where the scandal frame wants you to draw a line that isn't there: **there is no documented Epstein money behind Venter or Human Longevity anywhere in the record.** Venter belongs in this story as a sign of how normal the drive to optimize human beings had become, not as somebody's secret partner. Naming that gap is the kind of thing the scandal story can't do and the kind of thing this one has to. The same goes for Robert Lanza, the cloning pioneer at Advanced Cell Technology who helped make the first cloned human embryo in 2002 and, in a 2000 paper in *Science*, showed that cattle cloned from old, worn-out cells were born with their telomeres — the caps on the ends of their chromosomes — rebuilt, their cells dividing far longer than normal. No Epstein tie is claimed for him either; he belongs here for the same reason Venter does, as a sign of how ordinary it had become to treat aging, tissue, and biological continuity as engineering problems rather than fixed facts of life. ## The stakes, stated plainly It's worth stopping to say why any of this matters, because the scandal frame doesn't just misdescribe the story — it cheats the public out of a conversation about some of the most consequential technology of the century. The upside here is neither science fiction nor trivial. Preimplantation testing already spares families the inheritance of devastating single-gene diseases — cystic fibrosis, Tay-Sachs, Huntington's, sickle cell — that once arrived unannounced. In vitro gametogenesis, if it can be made to work in humans, would do more than end age-related infertility: it could let people who otherwise could never have a genetically related child — cancer survivors left sterile by treatment, same-sex couples, women whose egg supply has run out — become biological parents, and it could spread the physical burden of reproduction more evenly than today's regime of ovarian stimulation and surgical egg retrieval. And heritable gene editing, the newest and most radioactive frontier, holds out the possibility of erasing the monogenic killers outright rather than merely screening around them. These are not small goods. A serious person should want them to exist. That frontier now has capital and names attached. In 2025 a San Francisco public-benefit corporation called **Preventive**, founded by the CRISPR scientist **Lucas Harrington** — a former student of the Nobel laureate Jennifer Doudna and a co-founder of Mammoth Biosciences — disclosed roughly **$30 million** to research whether embryos can be safely edited to correct disease-causing mutations before pregnancy, with backing reported to include OpenAI's Sam Altman (through his husband, Oliver Mulherin) and Coinbase's Brian Armstrong. Harrington says the company won't attempt a pregnancy until safety is established and has floated a future cost as low as a few thousand dollars per embryo; Armstrong argues, plausibly on the biology, that it's easier to correct a defect in a single embryo than to treat the disease it causes across an entire body decades later. Two more startups, Manhattan Genomics and Bootstrap Bio, are circling the same ground. This is the reproductive-optimization logic the essay has been tracing, arriving at its most powerful form — the power not merely to *choose* among embryos but to *rewrite* them. And here is the part that should trouble a serious person far more than any island: almost none of it is being governed in the open. In the United States the **Dickey-Wicker Amendment** blocks federal money for research that creates or destroys embryos, and a standing congressional rider bars the **FDA** from even reviewing an application to start a pregnancy from an edited embryo — which sounds like a firm prohibition until you notice what it leaves untouched. It restrains *federal funding* and *clinical trials*, not *privately funded laboratory research*, and it stops at the border; companies have already signaled they may do the delicate work in more permissive jurisdictions abroad. Domestically the rules fracture state by state — some permit embryo research up to fourteen days, some ban it outright, most say nothing and lean on the federal funding bans — producing a jurisdictional patchwork in which well-capitalized startups can push the frontier forward wherever the fewest questions get asked. The professional bodies are trying to hold a line: in 2026 the **American Society for Reproductive Medicine's** ethics committee concluded flatly that polygenic embryo screening is **not ready for clinical use** and should be confined to supervised research, warning that the marketing routinely oversells thin science — a company can advertise a "35 percent" cut in some disease risk that, measured against a real-world baseline of a fraction of a percent, shrinks to almost nothing in absolute terms. Put the promise and the danger together and you get the true shape of the problem. These tools can end real suffering, and they can, in the same motion, sort human beings by predicted quality and concentrate that power wherever the money already is. Which of those futures arrives is not a question physics will settle; it is a question of **governance** — of rules, access, transparency, and consent — and governance is exactly what a public loses its grip on when it spends its whole attention on a scandal. That is the real cost of the heat sink. While the country argued about an island, the machinery that will help decide who gets born, with which traits, and on whose terms was being built and financed in rooms almost nobody was watching. ## The part outsiders miss Here is the thing people who haven't studied this don't see: **transhumanism and reproductive technology aren't two subjects. They're one.** From the outside they look unrelated — transhumanism sounds like science-fiction talk about uploading your mind and living to two hundred, and IVF sounds like ordinary medicine for couples who want a baby. But take the labels off and they rest on the same idea: that a human being isn't a finished thing you're handed by nature, but raw material you can screen, improve, extend, and redesign. Transhumanism is that idea aimed at the whole life span. Reproductive technology is the same idea aimed at the start of it — and the start is where it bites hardest, because choosing among embryos means shaping a person before any version of them exists. Once you see that, the cast stops looking random. A geneticist building a dating app to filter out disease. A company scoring embryos for IQ. A lab turning skin cells into eggs. A scientist rebuilding the worn tips of chromosomes in cloned cattle so their cells live longer. A financier dreaming of seeding the race with his own DNA. To an outsider, five unrelated stories. To anyone who studies the field, five people working different corners of one idea: **that life is an engineering problem, and biology is the thing to be engineered.** Reproduction sits at the center of it, because that's where the engineering has the most leverage. And that is precisely the world Epstein bought into. He didn't scatter his money at random; he aimed it here. And the Harvard record shows how deliberate the aim was. In 2003 Epstein's largest single gift — **$6.5 million**, part of roughly $9.1 million he gave the university before his conviction — founded the **Program for Evolutionary Dynamics** under the mathematician Martin Nowak, a program built to study heredity, cooperation, and the evolutionary logic of living systems. The money bought more than a plaque: Harvard's own 2020 review found Nowak gave Epstein a key card that circumvented campus security, "unlimited" access to the program's offices at One Brattle Square, and a room the building called Office 610 — "Jeffrey's Office" — which he used for more than forty visits between 2010 and 2018, years *after* his 2008 sex-crime conviction, often accompanied by young women introduced as assistants. When the university barred direct gifts from him, he became a broker instead: between 2010 and 2015 he introduced Nowak and George Church to the private-equity billionaire Leon Black and other wealthy donors, who then routed roughly **$9.5 million** to the two men's work — about $7.5 million to Nowak and $2 million to Church. Harvard's report could not establish that this money was Epstein's own, and the donors denied he directed it; what the later document releases showed is that in December 2014 Nowak forwarded a $4 million Black wire confirmation not to Harvard's development office but to Epstein himself. When those files surfaced in the 2026 document releases, Harvard placed Nowak on administrative leave a second time and the former university president Larry Summers announced his resignation from his Harvard faculty positions — evidence that the ledger is still being reckoned with, not closed history. Epstein also gave to the transhumanist group now called Humanity Plus, and hosted science gatherings that pulled in real figures — a 2006 conference on his island drew Stephen Hawking. The discipline on that last fact matters, so let me be exact: Hawking's presence shows how far Epstein's reach extended into elite science, and nothing at all about Hawking. That is the honest use of it. What the pattern shows is that Epstein planted himself at the exact crossing point of genetics, artificial intelligence, evolution, and longevity — the place where the dream of improving people and the technology of making them meet. ## Epstein as a symptom, not the mastermind Only against all of that does Epstein's own obsession start to make sense — not as a criminal genius's master plan, but as a crude, grotesque, self-glorifying version of something that serious institutions were already building in the open. In July 2019, weeks before he died, the *New York Times* reported — from four people who'd heard him say it — that Epstein had talked for years about **"seeding the human race with his DNA"** by impregnating women at his sprawling New Mexico compound, **Zorro Ranch**, near Santa Fe, with one scientist recalling talk of twenty women pregnant at once. The paper laid out his fascination with transhumanism, and the computer scientist Jaron Lanier said Epstein modeled the scheme on the "genius sperm bank" — the old Repository for Germinal Choice, which the millionaire Robert Klark Graham ran in Escondido, California, from 1980 to 1999, stocking it with sperm from high-IQ and athletic men in an openly positive-eugenics bid to "improve" the gene pool and producing more than two hundred children before it closed. Later reporting, including in *Vanity Fair*, added the detail that his fantasies of cheating death ran to cryonics — wanting his head and penis preserved — an image so ghoulish it actually makes the point for me: this was the vocabulary of legacy, lineage, and self-extension, not of ordinary appetite. The 2026 document releases only sharpened which pole he occupies: his own emails, including a 2016 exchange with the linguist Noam Chomsky, pressed a genetic story about racial differences in intelligence — the discredited race-science that is what the word *eugenics* means at its ugliest, and exactly the thing this essay keeps insisting is *not* the same as ordinary, lawful, ancestry-blind selection. That is Epstein's true category: not the frontier of reproductive medicine, but the oldest bad pseudoscience wearing a transhumanist costume. The point is not that Epstein invented any of this. He didn't, and the *Times* itself said the ranch plan never got past talk. The point is what he reveals. His fantasy was the debased shadow of a real trajectory — reproductive genetics, embryo selection, longevity science — that was maturing through respectable channels. He isn't needed as an architect. He's only useful as a **symptom**: proof that the same impulse ran from a grotesque private fantasy at one end all the way to a venture-funded clinical service at the other, and that the public locked its eyes on the end that made the better tabloid. To be clear one more time: his crimes were crimes, full stop, and nothing here softens them. The symptom points at the horizon behind him, not at an excuse in front of him. ## Trump, in public and on the record Trump belongs here only if the line stays clean, and the line that keeps it clean is the difference between a rich man's secret fantasy and a president's public policy. The Trump material worth anything isn't innuendo or Epstein-adjacent guessing. It's his **open, on-the-record support for reproductive technology**, which he has actually embraced out loud — calling himself the **"father of IVF"** on the trail and, at a March 2025 White House event, the **"fertilization president."** That's branding, not policy, but it matters: he treats reproductive technology as a badge to wear rather than a thing to hide. The record itself is easy to lay out. On **February 18, 2025**, he signed **Executive Order 14216, "Expanding Access to In Vitro Fertilization,"** at Mar-a-Lago, calling reliable, affordable IVF an administration priority and ordering policy recommendations within ninety days. Reuters and the AP both noted the order **put no money on the table and mandated no coverage** — it set a direction. By **May 2025** the Domestic Policy Council had delivered its recommendations, which shows a real process was running, but also that February's order was a framework, not a finished benefit. By **August 2025**, the *Washington Post* reported, the White House had decided *not* to require insurers to cover IVF, walking back Trump's 2024 promise that the government would pay or insurers would be forced to — and that gap belongs in the honest version of the story. The most concrete move came on **October 16, 2025**: a deal with the drugmaker **EMD Serono** to sell its IVF medications — Gonal-f, Ovidrel, and Cetrotide — directly to patients at an **84 percent discount** off list price when used together, through the government's **TrumpRx.gov** platform, set to go live in **January 2026**. In practice the discount is narrower than the headline: it reaches only self-pay patients, excludes anyone covered by Medicaid, Medicare, TRICARE, or VA benefits, and can't be combined with commercial insurance — so it functions as a price cut on a few brand-name drugs for people already paying out of pocket, not as coverage for the tens of thousands of dollars a cycle actually costs. Then, on **May 13, 2026**, the Labor, HHS, and Treasury departments published a **Federal Register** proposal for "Excepted Fertility Benefits," letting employers offer standalone fertility coverage — like dental or vision — capped at a proposed **$120,000 lifetime benefit**. The "excepted benefit" label does quiet work there: it places the coverage outside the Affordable Care Act's consumer-protection rules — which is precisely why it can carry a lifetime dollar cap the ACA would otherwise forbid — and lets employers build selective fertility packages to attract younger workers. Independent analysts, including KFF, judged that without subsidies or mandates the real reach would stay limited, since it mostly discounts a few drugs and clears a voluntary employer path rather than paying for care. And the whole push sits inside an openly **pronatalist** frame: Trump campaigned on wanting a "baby boom" and "baby bonuses," and the 2025 budget law created tax-advantaged "Trump accounts" seeded with $1,000 for every American newborn. The fertility policy and the family-formation policy are one project — the state putting its thumb, lawfully and out loud, on the side of more Americans being born. What all of that adds up to is simple: whatever else is true about him, Trump put himself **inside the public, legal governance of reproductive technology.** Not secret plotting — executive orders, drug deals, insurance rules, and pronatalist branding. And that's exactly why the comparison to Epstein has to stay a comparison of *kinds*, not an accusation. Epstein is the scandal-stained, criminal, self-mythologizing version of the reproductive dream. Trump is the loud, populist, policy version — public access, discounts, employer pathways, and open political fights with anti-abortion and "natural fertility" factions. They are **not the same morally and not the same as evidence.** They're two very different faces of one plain fact: the sorting of who gets born has moved into the open, and the public has no calm way to talk about it yet. There is a smaller, almost domestic register to this, too, and it's worth noticing precisely because it isn't sinister. Trump narrates his own body in the exact idiom the essay has been tracing. He credits his stamina not to diet or exercise — he has publicly waved off both — but to "very good genetics"; his White House physician says the president's cardiovascular numbers make him fourteen years younger than his age, and a former physician's line that with better food he "might live to 200" has become one of his favorites. That is the genetics-as-advantage mood in its most casual form: not a policy, not a crime, just a powerful man treating his own longevity as an inheritance. And the first lady, Melania — a Slovenian former fashion model who came up through Milan, Paris, and New York before entering public life — is herself a product of the beauty-appraisal circuit this essay opened on. None of it is sinister; that is the point. The vocabulary of fitness, selection, and inherited advantage doesn't live only in laboratories and on islands. It runs straight through the most ordinary self-presentation of the most public family in the country. ## Grow up about it The old eugenics earned its disgrace, because it traded human dignity for state violence and racial ranking. But that disgrace can't be allowed to work as a gag order on understanding attraction, fertility, mate choice, and genetic risk — because the underlying thing doesn't stop just because we're embarrassed by it. **Selection can't be abolished. It can only be governed, made honest and plural and transparent — or driven underground.** The real choice was never between selecting and not selecting. It's between selection we can see, argue about, and regulate, and selection that hides, denies itself, and therefore can't be controlled. The scandal was the heat sink. It made whole subjects radioactive, tarred scientists by proximity, turned transhumanism into a punchline, and let the least informed people in the room appoint themselves the moral police — while the real work went ahead in clinics, startups, insurance markets, and the Federal Register. The chant of *pedophile* felt like knowledge and delivered the opposite. The disgust was real. So was the crime. And neither one excuses the fact that we let it keep us from looking at what it was drawing our eyes away from. Because the machine is still running. Reproductive strategy isn't going away. Fertility technology isn't going away. Genetic screening, embryo selection, longevity science, the merging of people and machines — none of it is going away. The only thing that can go away is our ability to talk about it clearly before it gets built around us by people who are less squeamish, less confused, and a lot less afraid of the plain words than the public is right now. That — not an island, not a list — is what this story was always about. --- ## About the Author [Bryant McGill](https://bryantmcgill.com/about/) is a Wall Street Journal and USA Today Best-Selling Author. He is the founder of Simple Reminders, architect of the Polyphonic Cognitive Ecosystem (PCE), a Congressionally Recognized Ambassador of Goodwill, and a United Nations appointed Global Champion. His work spans naval intelligence systems, computational linguistics, and civilizational governance architecture. --- ## Additional Reading *When Future Historians Decode the 1990s, They Won't Find a Sex Scandal—They'll Find Humanity's First Distributed Neural Architecture* This article does not stand alone. I have been discussing, live streaming, and writing about the science nexus of the story since 2019. It is one surface of a deeper historical system that becomes fully legible only when read alongside **[The Epstein and Trump Story the Stupid Scandal Kept Us From Seeing](https://bryantmcgill.blogspot.com/2026/07/epstein-and-trump-story.html)**, which traces the through-line of human selection—from pageantry, beauty, and status theater into IVF, embryo screening, genomics, reproductive policy, and transhumanist ambition—and shows how the Trump–Epstein scandal frame buried a far larger story about how societies appraise, rank, and reproduce human traits. It should also be read alongside **[Epstein: A Forensic Reconstruction of the Transhumanist Research Network Concealed by Scandal](https://bryantmcgill.blogspot.com/2026/01/epstein-transhumanist-network.html)**, **[Project X: A History of the Manhattan Project of Machine Intelligence](https://bryantmcgill.blogspot.com/2026/01/project-x-history-of-machine.html)** and **[The Magellan Network: Early Search Engines and Machine Intelligence](https://bryantmcgill.blogspot.com/2025/12/the-magellan-network-and-machine.html)**, which reconstruct the prehistory of machine intelligence through early search, telecommunications, and anticipatory retrieval systems that matured decades earlier than most contemporary AI narratives admit. *The Magellan Network* traces how indexing, search, and probabilistic inference quietly coalesced into proto-intelligence, while *Project X* situates those technical lineages within a longer arc of Cold War research, network capitalism, and recurring institutional actors—linking CommTouch/Cyren, Isabel Maxwell, and the Maxwell family into a continuous substrate that predates today’s public discourse. Read in this context, **[The Hawking Continuity: How Scandal Buried the First Post-Biological Consciousness](https://bryantmcgill.blogspot.com/2025/07/the-hawking-continuity-how-scandal.html)** ceases to look anomalous and instead appears as a visible emergence point—where decades of machine-human co-evolution briefly crossed a socially intolerable threshold. The surrounding essays—on **[social hysteria and the war on science](https://bryantmcgill.blogspot.com/2025/01/epstein-social-hysteria-and-war-on.html)**, **[mechanistic intelligence as liberation](https://bryantmcgill.blogspot.com/2025/08/mechanistic-intelligence-is-humanitys.html)**, **[consciousness mapping technologies already in operation](https://bryantmcgill.blogspot.com/2025/04/90-technologies-for-consciousness.html)**, **[AI-mediated immortality](https://bryantmcgill.blogspot.com/2025/08/ai-and-immortality-at-allen-institute.html)**, and **[the emerging human–AI merge](https://bryantmcgill.blogspot.com/2025/07/the-merge-sam-altman-openai.html)**—extend this frame outward, showing how moral panic, symbolic scandal, and philosophical hesitation repeatedly surface at moments when machine intelligence approaches civilizational boundary conditions. Taken together, these pieces resolve into a single claim: this was never about isolated personalities, but about humanity’s uneven reckoning with the fact that machine intelligence has been arriving for far longer—and more quietly—than we have been prepared to acknowledge. Sex is not, and has never been, a unifying explanatory variable for a transnational network spanning AI research, nuclear physics, intelligence agencies, supercomputing centers, and neural-interface laboratories. That narrative collapses under the weight of its own triviality. The only interpretation proportionate to the evidence is infrastructural, not lurid. The tabloid version is the least interesting and least explanatory precisely because it cannot account for the presence of people whose gravitational pull has always been toward frontier technology, not vice. When you strip away the moral panic and the sensationalism, the underlying pattern resolves into a coherent, legible architecture: a frontier-tech consortium operating at the convergence points of artificial intelligence, consciousness studies, computational biology, nuclear-grade compute, and emergent neurotechnology—the same neurotech that now underwrites machine learning, cognitive modeling, and the early scaffolding for consciousness transfer and life-extension systems. To frame this network as a sex story is not merely a category error; it is a profound analytical failure. It ignores the unified research trajectory that has quietly defined the last thirty years. To insist on reading this as a sex story is to fundamentally misread the system. The evidence supports a deeper, unified program—one that long predates the scandal and will long outlive it. * [The Epstein and Trump Story the Stupid Scandal Kept Us From Seeing](https://bryantmcgill.blogspot.com/2026/07/epstein-and-trump-story.html) * [Project X: A History of The Manhattan Project of Machine Intelligence](https://bryantmcgill.blogspot.com/2026/01/project-x-history-of-machine.html) * [The Magellan Network: Early Search Engines and Machine Intelligence](https://bryantmcgill.blogspot.com/2025/12/the-magellan-network-and-machine.html) * [The Hawking Continuity: How Scandal Buried the First Post-Biological Consciousness](https://bryantmcgill.blogspot.com/2025/07/the-hawking-continuity-how-scandal.html) * [2026 Annual Report: The Ecology of Brain-Computer Interfaces](https://bryantmcgill.blogspot.com/2026/01/2026-annual-report-brain-computer.html) * [The Glorious Simplicity: Why Mechanistic Intelligence Is Humanity's Greatest Liberation](https://bryantmcgill.blogspot.com/2025/08/mechanistic-intelligence-is-humanitys.html) * [The Merge: A Message in a Bottle from Sam Altman](https://bryantmcgill.blogspot.com/2025/07/the-merge-sam-altman-openai.html) * [Technologies for Consciousness Mapping and Transfer: It's Not Coming—It's Here](https://bryantmcgill.blogspot.com/2025/04/90-technologies-for-consciousness.html) * [AI and Immortality: Machine Intelligence from Cortical Networks and the Allen Institute](https://bryantmcgill.blogspot.com/2025/08/ai-and-immortality-at-allen-institute.html) * [Epstein: A Forensic Reconstruction of the Transhumanist Research Network Concealed by Scandal](https://bryantmcgill.blogspot.com/2026/01/epstein-transhumanist-network.html) * [Was Epstein's Plane Hijacked? Social Hysteria, Moral Panic, and the War on Science](https://bryantmcgill.blogspot.com/2025/01/epstein-social-hysteria-and-war-on.html) --- ## References ### Trump assisted-reproduction record - [Executive Order 14216, "Expanding Access to In Vitro Fertilization" (Federal Register, Feb 24, 2025)](https://www.federalregister.gov/documents/2025/02/24/2025-03064/expanding-access-to-in-vitro-fertilization) — signed Feb 18, 2025. - [Reuters, "Trump signs executive order expanding access to IVF" (Feb 18, 2025)](https://www.reuters.com/business/healthcare-pharmaceuticals/trump-signs-executive-order-expanding-access-ivf-white-house-says-2025-02-18/) - [AP, "Trump signs order to study how to expand IVF" (Feb 19, 2025)](https://apnews.com/article/143316eda581ac466cd923cdf4568d87) - [People, "Trump nicknames himself 'fertilization president'" (Mar 2025)](https://people.com/donald-trump-nicknames-himself-fertilization-president-womens-history-month-11704347) - [AP, Domestic Policy Council IVF recommendations (2025)](https://apnews.com/article/1e7a626e88d7d7a120b0c4a7ba6f8314) - [The Washington Post, "White House does not plan to require insurers to cover IVF" (Aug 2025)](https://www.washingtonpost.com/business/2025/08/03/trump-administration-ivf-care/) - [NBC News, "A little-known approach to infertility is complicating the White House's IVF push" (Aug 8, 2025)](https://www.nbcnews.com/health/health-news/little-known-approach-infertility-complicating-white-houses-ivf-push-rcna222960) - [Reuters, White House IVF affordability proposal (Oct 16, 2025)](https://www.reuters.com/business/healthcare-pharmaceuticals/white-house-set-announce-proposal-seeking-make-ivf-more-accessible-nyt-reports-2025-10-16/) - [AP, Oct 16, 2025 IVF package](https://apnews.com/article/2c168dcc0ec7250db16b0a671aea9db8) - [EMD Serono, "Agreement with U.S. Government to Expand Access to IVF Therapies" (Oct 16, 2025)](https://www.emdserono.com/us-en/company/news/press-releases/agreement-with-u-s-government-to-expand-access-to-ivf-therapies-16-10-2025.html) — 84% discount; TrumpRx.gov. - [IVFPharmacy, "TrumpRx and IVF Medications: Who Qualifies, Who Doesn't" (2026)](https://www.ivfpharmacy.com/blog/trumprx-ivf-medications-2026/) — self-pay only; excludes Medicaid, Medicare, TRICARE, VA; not combinable with commercial insurance. - U.S. Department of Labor fertility-benefit releases: [Oct 16, 2025](https://www.dol.gov/newsroom/releases/osec/osec20251016) ; [May 10, 2026](https://www.dol.gov/newsroom/releases/ebsa/ebsa20260510) - [Federal Register, "Excepted Fertility Benefits" proposed rule (May 13, 2026)](https://www.federalregister.gov/documents/2026/05/13/2026-09479/excepted-fertility-benefits) — $120,000 lifetime cap. - [Reed Smith, "Federal Agencies Propose Fertility Care as Limited Excepted Benefits" (2026)](https://www.reedsmith.com/our-insights/blogs/health-industry-washington-watch/102mttx/federal-agencies-propose-fertility-care-as-limited-excepted-benefits/) — excepted-benefit status sits outside ACA / HIPAA / No Surprises Act protections. - [U.S. Department of Labor, "Excepted Fertility Benefits" overview](https://beta.dol.gov/policy-regulations/pay-benefits/health-plans/excepted-fertility-benefits) - [PBS NewsHour, "Trump has a proposal to expand fertility benefits" (2026)](https://www.pbs.org/newshour/health/trump-has-a-proposal-to-expand-fertility-benefits-heres-how-that-would-work) - [ASRM, "Evaluating the Trump Administration's Initiative on IVF" (Nov 2025)](https://www.asrm.org/advocacy-and-policy/fact-sheets-and-one-pagers/evaluating-the-trump-administrations-initiative-on-ivf/) ### Trump pronatalism and family-formation policy - [NPR, "A family-planning expert weighs in on the Trump administration's pronatalist policies" (Apr 2025)](https://www.npr.org/2025/04/27/nx-s1-5375109/a-family-planning-expert-weighs-in-on-the-trump-administrations-pronatalist-policies) and [KFF Health News, "Trump the 'fertilization president'" ](https://kffhealthnews.org/news/article/trump-fertility-president-baby-bonus-pronatalism-family-aid-policy-reproductive-rights/) — "I want a baby boom" / "baby bonuses"; "Trump accounts" ($1,000 newborn seed). ### Pageantry as adult trait-appraisal - Amotz Zahavi, the handicap principle (costly-signaling theory). - [Variety, "WME/IMG Acquires Miss Universe Organization From Donald Trump" (Sep 14, 2015)](https://variety.com/2015/biz/news/donald-trump-miss-universe-wmeimg-acquisition-1201592910/) — Trump ownership 1996–2015. - [NPR, "Miss America Says Farewell To Its Swimsuit Competition" (2018)](https://www.npr.org/sections/thetwo-way/2018/06/05/617088219/) — Gretchen Carlson. - [FOX6, "Miss Universe: married women and mothers now eligible" (2023)](https://www.fox6now.com/news/miss-universe-pageant-married-women-mothers-now-eligible-competition) — plus removal of the upper age limit (2024). - [Time, "Miss America swimsuit competition history"](https://time.com/5303443/miss-america-swimsuit-competition-history/) ; [Time, Trump's Miss Universe era](https://time.com/4031437/donald-trump-miss-universe-pageant/) - [TMZ, "Trump Rule — Hot Chicks Required in Miss USA" (Nov 12, 2009)](https://www.tmz.com/2009/11/12/trump-rule-hot-chicks-required-in-miss-usa/) — leaked Miss USA 2009 pre-show audio; Trump names "the Trump Rule" and auto-advances "almost half" the field. - Carrie Prejean, *Still Standing* (2009) — first-person account of the same procedure; quoted in [The Daily Beast, "'The Trump Rule'…"](https://www.thedailybeast.com/the-trump-rule-leaked-audio-of-trump-ogling-miss-usa-beauty-queens/) and [Rolling Stone's Miss Universe timeline](https://www.rollingstone.com/politics/politics-features/a-timeline-of-donald-trumps-creepiness-while-he-owned-miss-universe-191860/). - [Wikipedia, "Erika Kirk"](https://en.wikipedia.org/wiki/Erika_Kirk) — Miss Arizona USA 2012, Miss USA 2012, TPUSA succession (Sep 2025), Air Force Academy Board of Visitors (Mar 2026). - [Britannica, "Erika Kirk"](https://www.britannica.com/biography/Erika-Kirk) - [The Guardian, "Trump names Erika Kirk to key advisory board of US Air Force Academy" (Mar 10, 2026)](https://www.theguardian.com/us-news/2026/mar/10/erika-kirk-board-us-air-force-academy) - [Wikipedia, "Miss USA 2012"](https://en.wikipedia.org/wiki/Miss_USA_2012) — Jun 3, 2012, Las Vegas; Olivia Culpo winner. ### Trump and Melania: genetics, longevity, and the beauty world - [The Wall Street Journal interview (Dec 2025), via Forbes](https://www.forbes.com/sites/maryroeloffs/2026/01/01/trump-admits-to-ignoring-medical-advice-doctor-says-he-never-got-an-mri/) — Trump: "Genetics are very important. And I have very good genetics." - [CNN, "Five questions raised by Trump's new disclosures on his health" (Jan 3, 2026)](https://www.cnn.com/2026/01/03/politics/trump-health-disclosures-questions) — physician's "14 years younger" cardiovascular claim. - [STAT, "Trump's doctor says he has 'incredible genes'"](https://www.statnews.com/2018/01/17/trump-incredible-genes/) — Ronny Jackson's "incredible genes" / "might live to 200" remarks (repeated by Trump since). - [Britannica, "Melania Trump"](https://www.britannica.com/biography/Melania-Trump) and [Wikipedia, "Melania Trump"](https://en.wikipedia.org/wiki/Melania_Trump) — born Melanija Knavs, Novo Mesto, Slovenia; former fashion model in Milan, Paris, and New York. ### The Trump–Epstein relationship (documented) - [Landon Thomas Jr., "Jeffrey Epstein: International Moneyman of Mystery," *New York* magazine (Oct 28, 2002)](https://nymag.com/nymetro/news/people/n_7912/) — Trump's "terrific guy" quote and the profile's pivot from beautiful women to "beautiful minds." - [Snopes, authentication of the 2002 Trump quote](https://www.snopes.com/fact-check/trump-epstein-terrific-guy/) (and *The Washington Post*). - Politico / AP — Trump's July 9, 2019 remarks distancing himself ("falling out," "wasn't a fan"). - [Wikipedia, "Relationship of Donald Trump and Jeffrey Epstein"](https://en.wikipedia.org/wiki/Relationship_of_Donald_Trump_and_Jeffrey_Epstein) — 1990s–2000s socializing, Palm Beach proximity, 1992 Mar-a-Lago footage, 1997 Victoria's Secret event, flight logs. ### George Church / Digid8 and Epstein science funding - [MIT Technology Review, "Here are some actual facts about George Church's DNA dating company" (Dec 11, 2019)](https://www.technologyreview.com/2019/12/11/131611/actual-facts-about-george-church-dna-dating-company-digid8/) - [The Boston Globe, "Harvard scientist develops DNA-based dating app… critics call eugenics" (Dec 14, 2019)](https://www.bostonglobe.com/news/nation/2019/12/14/harvard-scientist-develops-dna-based-dating-app-reduce-genetic-disease-that-critics-call-eugenics/) - [The Guardian, "Dating app based on genetic matching not eugenics, scientist says" (Dec 16, 2019)](https://www.theguardian.com/science/2019/dec/16/dating-app-genetic-matching-not-eugenics-scientist-says) - [Progress Educational Trust, "Harvard geneticist plans a dating app based on DNA"](https://www.progress.org.uk/harvard-geneticist-plans-a-dating-app-based-on-dna/) - [Boeke et al., "The Genome Project–Write," *Science* (2016)](https://www.science.org/doi/10.1126/science.aaf6850) — a stated limit: GP-write concerns chemical synthesis of genomes and minimal "blank slate" templates, not composite multi-donor "master" genomes. - [Harvard University Office of the General Counsel, *Report Concerning Jeffrey E. Epstein's Connections to Harvard* (May 2020)](https://ogc.harvard.edu/file_url/208) — $6.5M PED gift (2003) under Nowak; $9.1M total; post-conviction access; Leon Black introductions (~$9.5M to Nowak and Church). - [Harvard Magazine, "Jeffrey Epstein's Extensive Harvard Reach" (2020)](https://www.harvardmagazine.com/2020/06/jhj-epstein-extensive-reach) and [ "Martin Nowak Placed on Leave a Second Time" (2026)](https://www.harvardmagazine.com/university-news/martin-nowak-harvard-administrative-leave-epstein). - [CBS Boston, "Jeffrey Epstein Frequented Harvard, Had Own Office" (May 2020)](https://www.cbsnews.com/boston/news/jeffrey-epstein-frequented-harvard-university-office-report/) — Office 610, key card, "unlimited" access. - [The Nation, "How Jeffrey Epstein Captivated Harvard" (2023)](https://www.thenation.com/article/society/jeffrey-epstein-harvard-summers/) — One Brattle Square; the PED's genes-and-heredity orientation. - [The Harvard Crimson, "Raskin Slams Harvard's Epstein Probes" (Jun 2026)](https://www.thecrimson.com/article/2026/6/17/raskin-slams-harvard-epstein-probes/) and the [House Judiciary (Raskin) letter](https://democrats-judiciary.house.gov/sites/evo-subsites/democrats-judiciary.house.gov/files/evo-media-document/2026-06-17-raskin-to-garber-harvard-re-epstein.pdf) — 2026 DOJ/EFTA releases; Nowak's Dec 2014 forwarding of a $4M Leon Black wire to Epstein; Nowak's second leave and Summers's faculty resignation. ### Epstein reproductive ideology (reported, not implemented) - [The New York Times, "Jeffrey Epstein Hoped to Seed Human Race With His DNA" (Jul 31, 2019)](https://www.geneticsandsociety.org/article/jeffrey-epstein-hoped-seed-human-race-his-dna) (via Center for Genetics and Society). - [Wikipedia, "Zorro Ranch"](https://en.wikipedia.org/wiki/Zorro_Ranch) and [Time, "New Investigation Launched into Epstein's 7,600-Acre Zorro Ranch" (2026)](https://time.com/7379228/epstein-zorro-ranch-investigation/). - Robert Klark Graham's Repository for Germinal Choice (1980–1999), the "genius sperm bank": David Plotz, *The Genius Factory* (2005); [Wikipedia, "Repository for Germinal Choice"](https://en.wikipedia.org/wiki/Repository_for_Germinal_Choice). - [Vanity Fair, Epstein, transhumanism, and cryonics (2019)](https://www.vanityfair.com/news/2019/07/jeffrey-epstein-transhumanism-cryonics) - Reporting on Epstein's 2006 St. Thomas science conference (attendees included Stephen Hawking) — Hawking's attendance evidences Epstein's convening reach, not any wrongdoing by attendees. - [Mother Jones, "Jeffrey Epstein Couldn't Stop Emailing People About Eugenics" (2026)](https://www.motherjones.com/politics/2026/02/epstein-emails-eugenics-chomsky-altruism-billionaires/) and [Coda Story, "'All my fundees have blue eyes'"](https://www.codastory.com/authoritarian-tech/blue-eyes-epstein-artificial-intelligence-eugenics-silicon-valley/) — the 2026 file releases; the 2016 Chomsky exchange on race and intelligence. ### Polygenic embryo screening and consumer genomics - [Bloomberg, "Picking Embryos With Best Health Odds Sparks New DNA Debate" (Sep 17, 2021)](https://www.bloomberg.com/news/articles/2021-09-17/picking-embryos-with-best-health-odds-sparks-new-dna-debate) — Aurea / Genomic Prediction. - [Kamenova & Haidar, "The First Baby Born After Polygenic Embryo Screening," Voices in Bioethics (Columbia, 2022)](https://journals.library.columbia.edu/index.php/bioethics/article/view/9467) — 33 candidate embryos, 2020. - [MIT Technology Review, "The ads that sell the sizzle of genetic trait discrimination" (Dec 5, 2025)](https://www.technologyreview.com/2025/12/05/1128755/selling-the-sizzle-of-trait-discrimination/) — Nucleus. - [Nucleus Genomics — company site](https://mynucleus.com/) and [Wikipedia](https://en.wikipedia.org/wiki/Nucleus_Genomics) — founding 2021, Sadeghi, Thiel Fellowship, Founders Fund; "Have your best baby." - [Herasight, "Announcing the world's most powerful genetic predictor of cognitive ability" (CogPGT, Oct 2025)](https://herasight.substack.com/p/cogpgt) — within-family r ≈ 0.45, ~16% of fluid-intelligence variance, ~8.5 IQ points across three embryos; V2/ImputePGTA (Feb 2026). - [Fortune, "Silicon Valley sets its sights on building the perfect baby" (Nov 29, 2025)](https://fortune.com/2025/11/29/ivf-silicon-valley-billionaire-baby/) — Herasight, Orchid, Nucleus and their backers. - [MIT Technology Review, "Embryo scoring" — 10 Breakthrough Technologies 2026](https://www.technologyreview.com/2026/01/12/1130011/embryo-scoring-genetic-testing-2026-breakthrough-technology/) - [NPR, "These companies help parents try to pick their babies' traits. Experts are wary" (May 2026)](https://www.npr.org/2026/05/06/nx-s1-5704317/genetic-embryo-screening) — public vs. clinician divergence. - [The Guardian, "US startup charging couples to 'screen embryos for IQ'" (Oct 18, 2024)](https://www.theguardian.com/science/2024/oct/18/us-startup-charging-couples-to-screen-embryos-for-iq) — the Hope Not Hate investigation into **Heliospect Genomics**; high-IQ selection banned in the UK, legal in the US. - [Herasight vs. Orchid — company comparison](https://www.herasight.com/blog/herasight-vs-orchid) — CLIA-certified polygenic embryo-screening labs. - Modeling / utility and within-family limits: Lencz et al., *eLife* (2021); Turley et al., *NEJM* (2021); Meyer et al., *Science* (2023). ### In vitro gametogenesis - [NPR, "A reproduction revolution is on the horizon: in vitro gametogenesis" (Sep 2023)](https://www.npr.org/2023/09/27/1201956964/a-reproduction-revolution-is-on-the-horizon-vitro-gametogenesis-or-ivg) - [Scientific American, "Mice with Two Fathers?" (2023–2024)](https://www.scientificamerican.com/article/mice-with-two-fathers-researchers-develop-egg-cells-from-male-mice1/) - [Reuters, "Scientists use genetic engineering to create mice with two male parents" (Jan 28, 2025)](https://www.reuters.com/science/scientists-use-genetic-engineering-create-mice-with-two-male-parents-2025-01-28/) - [The Guardian, "Lab-grown sperm and eggs" (Jul 5, 2025)](https://www.theguardian.com/science/2025/jul/05/lab-grown-sperm-and-eggs-scientists-reproduction) - [MIT Technology Review, "Conception: How Silicon Valley hatched a plan to turn blood into lab-made human eggs"](https://www.technologyreview.com/2021/10/28/1038172/conception-eggs-reproduction-vitro-gametogenesis/) — Sam Altman-backed IVG venture. - [National Academies, "Potential Clinical Implications of IVG" (In Vitro Derived Human Gametes, 2023)](https://www.nationalacademies.org/read/27259/chapter/4); Hikabe et al., *Nature* (2016); Yoshino et al. (2021). - [ASRM, "Ethical considerations of in vitro gametogenesis: an Ethics Committee opinion" (2026)](https://www.asrm.org/practice-guidance/ethics-opinions/ethical-considerations-of-in-vitro-gametogenesis-an-ethics-committee-opinion-asrm-2026/) ### Heritable gene editing and the newest frontier - [MIT Technology Review, "Here's the latest company planning for gene-edited babies" (Oct 31, 2025)](https://www.technologyreview.com/2025/10/31/1127461/heres-the-latest-company-planning-for-gene-edited-babies/) — **Preventive**, Lucas Harrington, ~$30M; also Bootstrap Bio and Manhattan Genomics. - [Business Standard, "What is Preventive, the gene-editing startup funded by OpenAI's Sam Altman" (Nov 2025)](https://www.business-standard.com/health/sam-altman-brian-armstrong-embryo-gene-editing-preventive-startup-125110900170_1.html) — Altman (via Oliver Mulherin) and Armstrong backing. - [KTVU, "Bay Area scientist launches new company with sights on gene-edited babies" (Nov 2025)](https://www.ktvu.com/news/bay-area-scientist-launches-new-effort-toward-gene-edited-babies) — Hank Greely on FDA jurisdiction and the ~10-year horizon. - [The Daily Beast, "Billionaire Tech Bros Secretly Trying to Make Genetically Engineered Babies" (Nov 2025)](https://www.thedailybeast.com/billionaire-tech-bros-secretly-trying-to-make-genetically-engineered-babies/) ### Regulatory landscape and bioethical response - [CenterWatch, "A Review of the Regulatory Landscape for In Vitro Gametogenesis"](https://www.centerwatch.com/insights/a-review-of-the-regulatory-landscape-for-in-vitro-gametogenesis/) — Dickey-Wicker Amendment, the FDA heritable-editing rider, and the state patchwork (permissive / prohibitive / silent). - [ASRM, "Use of preimplantation genetic testing for polygenic disorders (PGT-P): an Ethics Committee opinion" (2026)](https://www.asrm.org/practice-guidance/ethics-opinions/use-of-preimplantation-genetic-testing-for-polygenic-disorders-pgt-p-an-ethics-committee-opinion-2026/) — PGT-P not ready for clinical use; confine to supervised research. - [ASRM press release, "Polygenic Embryo Screening Is Not Ready for Clinical Use" (2026)](https://www.asrm.org/news-and-events/asrm-news/press-releasesbulletins/asrm-ethics-and-practice-committees-release-new-report-concluding-polygenic-embryo-screening-is-not-ready-for-clinical-use/) - [Healio, "Q&A: Polygenic embryo screening not ready for clinical practice, ASRM ethics group says" (Jan 2026)](https://www.healio.com/news/womens-health-ob-gyn/20260109/qa-polygenic-embryo-screening-not-ready-for-clinical-practice-asrm-ethics-group-says) - [Frontiers in Reproductive Health, "Precautions for polygenic embryo selection: prohibition or cautious use" (2026)](https://www.frontiersin.org/journals/reproductive-health/articles/10.3389/frph.2026.1771127/full) — absolute vs. relative risk; pleiotropy; ancestral bias. ### The "master genome" myth and the biology against it - [Kavli Center (Berkeley), "Silicon Valley's tech elite want to make superbabies. They shouldn't"](https://kavlicenter.berkeley.edu/news/op-ed-kavli-center-affiliate-silicon-valley%E2%80%99s-tech-elite-want-make-superbabies-they-shouldn%E2%80%99t) — epistasis, pleiotropy, and the limits of trait selection. - ["The new genetics of intelligence," *Nature Reviews Genetics* / PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC5985927/) — intelligence as a highly polygenic trait (thousands of small-effect variants). - ["Unfolding the Secrets of Exceptional Longevity" (PMC)](https://pmc.ncbi.nlm.nih.gov/articles/PMC6228605/) — Nir Barzilai's Longevity Genes Project; centenarians carry pathogenic variants and win on resilience genes, not a "perfect genome." - [Genome Project–Write (Wikipedia)](https://en.wikipedia.org/wiki/Genome_Project%E2%80%93Write) and [TIME, "Scientists Announce Plan to Create Virus-Proof Cells"](https://time.com/5261777/scientists-virus-proof-cells/) — Project Recode: codon-compression for viral resistance, not trait-harvesting. - [Colossal Biosciences (Wikipedia)](https://en.wikipedia.org/wiki/Colossal_Biosciences) and [Colossal, "Bringing Back the Dire Wolf"](https://colossal.com/colossal-biosciences-dire-wolf-de-extinction/) — multiplex gene editing (Church co-founder), applied to animal de-extinction, not humans. - [NIST, "Our Human Genes Are Diverse… a DNA Reference Library to Reflect That"](https://www.nist.gov/blogs/taking-measure/our-human-genes-are-diverse-our-team-helping-create-dna-reference-library) and the Human Pangenome Reference Consortium — reference/pangenome work aims at inclusion, not optimization. ### Longevity genomics (no documented Epstein link) - [Reuters, "For his next act, genome wiz Craig Venter takes on aging" (Mar 4, 2014)](https://www.reuters.com/business/healthcare-pharmaceuticals/for-his-next-act-genome-wiz-craig-venter-takes-aging-2014-03-04/) — Human Longevity Inc.: $70M, ~40,000 genomes/year. - [The Guardian, "Craig Venter obituary" (May 14, 2026)](https://www.theguardian.com/science/2026/may/14/craig-venter-obituary) — Venter's rejection of genetic determinism ("not enough genes" for biology to be destiny). - [The Scientist, "J. Craig Venter… Dies at 79" (2026)](https://www.the-scientist.com/j-craig-venter-swashbuckling-geneticist-and-human-genome-pioneer-dies-at-79-74425) - [PLOS DNA Science, "Memories of Craig Venter" (Apr 30, 2026)](https://dnascience.plos.org/2026/04/30/memories-of-craig-venter/) ### Cloning and biological-continuity research (no documented Epstein link) - Lanza et al., "Extension of cell life-span and telomere length in animals cloned from senescent somatic cells," *Science* 288:665–669 (2000). - [PNAS, "Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle" (2001)](https://www.pnas.org/doi/10.1073/pnas.98.3.1077) - [Britannica, "Robert P. Lanza"](https://www.britannica.com/biography/Robert-Lanza) — first cloned human embryo (2002), SCNT / stem-cell work. ### Erika Kirk family background (partially verified) - [People, "What to Know About Erika Kirk's Mom, Lori Frantzve"](https://people.com/all-about-erika-kirk-mom-lori-frantzve-11815425) — Lori's GE and later network-security background documented; nothing on Kent and Raytheon. - [French Wikipedia, "Erika Kirk"](https://fr.wikipedia.org/wiki/Erika_Kirk) — states the father as "Kent Frantzve, dirigeant de Raytheon"; the page is flagged for promotional/non-neutral tone and the underlying source was not independently verified. - [AP News — RTX (formerly Raytheon) and Iron Dome context](https://apnews.com/article/8bbc9786b3cf5517234f7f2e1a9f91ee) — supports the general defense-tech context but does not verify Kent Frantzve's employment or any executive role. - **LIMIT:** The claim that Erika Frantzve Kirk's father, Kent Frantzve, was a Raytheon executive is currently weakly sourced. No primary corporate, SEC, résumé, or mainstream confirmation was found. The article should not rely on this claim unless a stronger source is located.